Ignite Creation Date:
2024-05-06 @ 4:04 AM
Last Modification Date:
2024-10-26 @ 11:43 AM
Study NCT ID:
NCT02448381
Status:
COMPLETED
Last Update Posted:
2022-04-15
First Post:
2015-05-13
Brief Title:
FLASH Fluorescent Light Activated Synthetic Hypericin Clinical Study Topical SGX301 Synthetic Hypericin for the Treatment of Cutaneous T-Cell Lymphoma Mycosis Fungoides
Sponsor:
Soligenix
Organization:
Soligenix
Study Overview
Official Title:
A Phase 3 Multicenter Randomized Double-Blind Placebo Controlled Study to Determine the Efficacy of Topical SGX301 Synthetic Hypericin and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the use of SGX301 a topical photosensitizing agent to treat patients with patchplaque phase cutaneous T-cell lymphoma mycosis fungoides
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None